Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Barnes

Showing results (431-440 of 474) with videos related to

Pageof 48
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2011
Reciprocal metabolic perturbations in the adipose tissue and liver of GPIHBP1-deficient miceMichael M Weinstein, Christopher N Goulbourne, Brandon S J Davies, et al.
FEBS Open Bio|November 1, 2024
Lysine deacetylase inhibitors have low selectivity in cells and exhibit predominantly off-target effectsKiara E Bornes, Marcus A Moody, Thomas M Huckaba, et al.
Molecular Genetics and Metabolism|January 7, 2022
FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in childrenLisa G Riley, Michael Nafisinia, Minal J Menezes, et al.
Asia-Pacific Journal of Clinical Oncology|November 9, 2017
Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trialKathryn M Field, Greg Fitt, Mark A Rosenthal, et al.
BMJ Open|January 4, 2023
Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trialAmeneh Khatami, David A Foley, Morgyn S Warner, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 29, 2025
Impact of Modifiable Surgical Factors on Ossiculoplasty Outcomes After Controlling for Ear Environment Risk: A Multi-Institutional StudyRyan T Judd, Michael B Gluth, Richard K Gurgel, et al.
Neuro-Oncology|July 2, 2015
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastomaKathryn M Field, John Simes, Anna K Nowak, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 5, 2019
Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trialLauren R Olafson, Anna H Siddell, Kathryn M Field, et al.
Journal of the American Heart Association|October 25, 2013
Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease studyHarvey D White, John Simes, Ralph A H Stewart, et al.
Science (New York, N.Y.)|April 13, 2013
Self-assembling cages from coiled-coil peptide modulesJordan M Fletcher, Robert L Harniman, Frederick R H Barnes, et al.
Pageof 48

Showing results (431-440 of 474) with videos related to

Sort By:
Pageof 48
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2011
Reciprocal metabolic perturbations in the adipose tissue and liver of GPIHBP1-deficient miceMichael M Weinstein, Christopher N Goulbourne, Brandon S J Davies, et al.
FEBS Open Bio|November 1, 2024
Lysine deacetylase inhibitors have low selectivity in cells and exhibit predominantly off-target effectsKiara E Bornes, Marcus A Moody, Thomas M Huckaba, et al.
Molecular Genetics and Metabolism|January 7, 2022
FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in childrenLisa G Riley, Michael Nafisinia, Minal J Menezes, et al.
Asia-Pacific Journal of Clinical Oncology|November 9, 2017
Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trialKathryn M Field, Greg Fitt, Mark A Rosenthal, et al.
BMJ Open|January 4, 2023
Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trialAmeneh Khatami, David A Foley, Morgyn S Warner, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 29, 2025
Impact of Modifiable Surgical Factors on Ossiculoplasty Outcomes After Controlling for Ear Environment Risk: A Multi-Institutional StudyRyan T Judd, Michael B Gluth, Richard K Gurgel, et al.
Neuro-Oncology|July 2, 2015
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastomaKathryn M Field, John Simes, Anna K Nowak, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 5, 2019
Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trialLauren R Olafson, Anna H Siddell, Kathryn M Field, et al.
Journal of the American Heart Association|October 25, 2013
Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease studyHarvey D White, John Simes, Ralph A H Stewart, et al.
Science (New York, N.Y.)|April 13, 2013
Self-assembling cages from coiled-coil peptide modulesJordan M Fletcher, Robert L Harniman, Frederick R H Barnes, et al.
Pageof 48